Piperaquine
File:Piperaquine.png | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
UNII | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C29H32Cl2N6 |
Molar mass | 535.51 |
3D model (JSmol) | |
| |
(what is this?) (verify) |
WikiDoc Resources for Piperaquine |
Articles |
---|
Most recent articles on Piperaquine Most cited articles on Piperaquine |
Media |
Powerpoint slides on Piperaquine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Piperaquine at Clinical Trials.gov Clinical Trials on Piperaquine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Piperaquine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Piperaquine Discussion groups on Piperaquine Patient Handouts on Piperaquine Directions to Hospitals Treating Piperaquine Risk calculators and risk factors for Piperaquine
|
Healthcare Provider Resources |
Causes & Risk Factors for Piperaquine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Piperaquine is an antimalarial drug, a bisquinoline first synthesised in the 1960s, and used extensively in China and Indochina as prophylaxis and treatment during the next 20 years. Usage declined in the 1980s as piperaquine-resistant strains of P. falciparum arose and artemisinin-based antimalarials became available. However, Chinese scientists have been studying whether piperaquine can still be used therapeutically in combination with artemisinin.[1]
Piperaquine is characterized by slow absorption and a long biological half-life,[2] making it a good partner drug with artemisinin derivatives which are fast acting but have a short biological half-life.[3]
The fixed-dose combination dihydroartemisinin-piperaquine (Eurartesim) was submitted for approval to the European Medicines Agency in 2009.[4]
References
- ↑ Davis TM, Hung TY, Sim IK, Karunajeewa HA, Ilett KF (2005). "Piperaquine: a resurgent antimalarial drug". Drugs. 65 (1): 75–87. PMID 15610051.
- ↑ D'alessandro U. (2009). "Progress in the development of piperaquine combinations for the treatment of malaria". Curr Opin Infect Dis. 22 (6): 588–92. PMID 19773652.
- ↑ http://apps.who.int/prequal/info_applicants/Guidelines/Nonclinical_Overview_Artemisinin-Derivatives.pdf"
- ↑ Medicines for Malaria. "Registration". Retrieved 2010-06-20.
- Pages with script errors
- CS1 maint: Multiple names: authors list
- Pages with broken file links
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs missing an ATC code
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Antimalarial agents
- Piperazines
- Quinolines
- Organochlorides